Submissions from 2022
Rural-urban trends in congenital heart disease-related mortality in the United States, 1999 to 2019, Abdul Mannan Khan Minhas, Rachel A. Wyand, Robert W. Ariss, Salik Nazir, Vardhmaan Jain, Sadeer G. Al-Kindi, Michael D. Shapiro, William Campbell, Laurence Sperling, and Salim S. Virani
Demographic and regional trends of hypertrophic cardiomyopathy-related mortality in the United States, 1999 to 2019, Abdul Mannan Khan Minhas, Rachel A. Wyand, Robert W. Ariss, Salik Nazir, Muhammad Shahzeb Khan, Xiaoming Jia, Stephen J. Greene, Marat Fudim, Andrew Wang, and Salim S. Virani
Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults-A population-level analysis in the national health interview survey, Khurram Nasir, Isaac Acquah, Amit K. Dey, Tanushree Agrawal, Syed Zawahir Hassan, Kerri Glassner, Bincy Abraham, Eamonn M M. Quigley, Ron Blankstein, and Salim S. Virani
Imaging subclinical coronary atherosclerosis to guide lipid management, are we there yet?, Pamela Piña, Daniel Lorenzatti, Rita Paula, Jonathan Daich, Aldo L. Schenone, Carlos Gongora, Mario J. Garcia, Michael J. Blaha, Matthew J. Budoff, and Salim S. Virani
Association of low-density lipoprotein testing after an atherosclerotic cardiovascular event with subsequent statin adherence and intensification, Jamal S. Rana, Salim S. Virani, Howard H. Moffet, Jennifer Y. Liu, Landis A. Coghlan, Jitesh Vasadia, Christie M. Ballantyne, and Andrew J. Karter
World Heart Federation cholesterol roadmap 2022, Kausik K. Ray, Brian A. Ference, Tania Séverin, Dirk Blom, Stephen J. Nicholls, Mariko H. Shiba, Wael Almahmeed, Rodrigo Alonso, Marat Ezhov, and Salim S. Virani
Determinants of incident atherosclerotic cardiovascular disease events among those with absent coronary artery calcium: Multi-ethnic study of atherosclerosis, Mahmoud Al Rifai, Michael J. Blaha, Vijay Nambi, Steven J.C. Shea, Erin D. Michos, Roger S. Blumenthal, Christie M. Ballantyne, Moyses Szklo, Erin D. Michos, and Salim S. Virani
State-level social vulnerability index and healthcare access: The behavioral risk factor surveillance system survey, Mahmoud Al Rifai, Vardhmaan Jain, Safi U. Khan, Anupama BK, Jamal H. Mahar, Chayakrit Krittanawong, Shiva Raj Mishra, Sourbha S. Dani, Laura A. Petersen, and Salim S. Virani
Social vulnerability and COVID-19: An analysis of CDC data, Mahmoud Al Rifai, Vardhmaan Jain, Safi U. Khan, Khurram Nasir, Dongshan Zhu, Rhythm Vasudeva, Carl J. Lavie, Sunita Dodani, Laura A. Petersen, and Salim S. Virani
Social determinants of health and comorbidities among individuals with atherosclerotic cardiovascular disease: The behavioral risk factor surveillance system survey, Mahmoud Al Rifai, Xiaoming Jia, June Pickett, Aliza Hussain, Sankar Dass Navaneethan, Kim K. Birtcher, Christie Ballantyne, and Laura A. Petersen
Association of U.S. birth, duration of residence in the U.S., and atherosclerotic cardiovascular disease risk factors among Asian adults, Mahmoud Al Rifai, Sina Kianoush, Vardhmaan Jain, Parag H. Joshi, Miguel Cainzos-Achirica, Khurram Nasir, Anwar T. Merchant, Sunita Dodani, Zainab Samad, and Salim S. Virani
Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs, Mahmoud Al Rifai, Dhruv Mahtta, David J. Ramsey, Michelle T. Lee, Chayakrit Krittanawong, Sankar D. Navaneethan, L. Parker Gregg, Laura A. Petersen, and Salim S. Virani
Temporal changes in cost-related medication nonadherence by race/ethnicity and medicaid expansion: The behavioral risk factor surveillance system survey, Mahmoud Al Rifai, Dhruv Mahtta, Elizabeth M. Vaughan, Laura A. Petersen, and Salim S. Virani
SGLT-2 inhibitors for patients with heart failure: What have we learned recently?, Mahmoud Al Rifai, L. Kristin Newby, Ajith P. Nair, Arunima Misra, Joseph G. Rogers, Savitri Fedson, and Salim S. Virani
Statin use and risk of diabetes by subclinical atherosclerosis burden (from a multi-ethnic study of atherosclerosis report), Mahmoud Al Rifai, Moyses Szklo, Jaideep Patel, Michael J. Blaha, Christie M. Ballantyne, Vera Bittner, Pamela Morris, John W. McEvoy, Michael D. Shapiro, and Salim S. Virani
Correlates of glucagon-like peptide-1 receptor agonist use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus (from the department of veterans affairs), Mahmoud Al Rifai, Elizabeth M. Vaughan, Layla A. Abushamat, Michelle Lee, David J. Ramsey, Kartik Gupta, Sankar D. Navaneethan, and Salim S. Virani
Identifying differences: A key step in precision cardiovascular disease prevention, Mahmoud Al Rifai, Salim S. Virani, and Vijay Nambi
Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis, Mahmoud Al Rifai, Jie Yao, Xiuqing Guo, Wendy S. Post, Shaista Malik, Roger S. Blumenthal, Christie M. Ballantyne, Matthew Budoff, Kent D. Taylor, and Salim S. Virani
Discordance between standard equations for determination of LDL cholesterol in patients with atherosclerosis, Aparna Sajja, Hsin-Fang Li, Kateri J. Spinelli, Roger S. Blumenthal, Salim S. Virani, Seth S. Martin, and Ty J. Gluckman
Lipid lowering therapy in 2022 and beyond - How far we have come, Joseph J. Saseen and Salim S. Virani
Burden of cardiovascular risk factors and disease in five Asian groups in Catalonia: A disaggregated, population-based analysis of 121 000 first-generation Asian immigrants, Priyanka Satish, Emili Vela, Usama Bilal, Montse Cleries, Alka M. Kanaya, Namratha Kandula, Salim S. Virani, Nadia Islam, Javier Valero-Elizondo, and Tamer Yahya
Glucocentric drugs in cardiovascular disease protection and heart failure, Khawaja M. Talha, Gregg C. Fonarow, Salim S. Virani, and Javed Butler
State-level social vulnerability index and healthcare access in patients with atherosclerotic cardiovascular disease (from the BRFSS Survey), Zachary M. Thompson, Vardhmaan Jain, Yu Han Chen, Waleed Kayani, Ashley Patel, Sina Kianoush, Ankit Medhekar, Safi U. Khan, Jerin George, and Salim S. Virani
Adherence to lipid monitoring and its impact on treatment intensification of LDL-C lowering therapies at an urban academic medical center, Christine Tran, Victoria Vo Vo, Perry Taylor, Deborah A. Koehn, Salim S. Virani, and Dave L. Dixon
Heart disease and stroke statistics-2022 update: A report from the American Heart Association, Connie W. Tsao, Aaron W. Aday, Zaid I. Almarzooq, Alvaro Alonso, Andrea Z. Beaton, Marcio S. Bittencourt, Amelia k. Boehme, Alfred E. Buxton, April P. Carson, and Salim S. Virani
Trend, predictors, and outcomes of combined mitral valve replacement and coronary artery bypass graft in patients with concomitant mitral valve and coronary artery disease: A national inpatient sample database analysis, Waqas Ullah, Sajjad Gul, Sameer Saleem, Mubbasher Ameer Syed, Muhammad Zia Khan, Salman Zahid, Abdul Mannan Khan Minhas, Salim S. Virani, Mamas A. Mamas, and David L. Fischman
Predictors of in-hospital mortality in patients with end-stage renal disease undergoing transcatheter aortic valve replacement: A nationwide inpatient sample database analysis, Waqas Ullah, Munnam Jafar, Salman Zahid, Faizan Ahmed, Muhammad Zia Khan, Yasar Sattar, David L. Fischman, Salim S. Virani, and Mahboob Alam
Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the nationwide inpatient sample and nationwide readmission database, Waqas Ullah, Salman Zahid, Hamza Muhammadzai, Fouad Khalil, Arnav Kumar, Abdul Mannan Khan Minhas, Muhammad Zia Khan, Salim S. Virani, David L. Fischman, and Pinak Shah
Unfavorable social determinants of health are associated with higher burden of financial toxicity among patients with atherosclerotic cardiovascular disease in the US: Findings from the National Health Interview Survey, Javier Valero-Elizondo, Zulqarnain Javed, Rohan Khera, Mauricio E. Tano, Ramzi Dudum, Isaac Acquah, Adnan A. Hyder, Julia Andrieni, Garima Sharma, and Salim S. Virani
Long-term effectiveness of the TIME intervention to improve diabetes outcomes in low-income settings: A 2-year follow-up, Elizabeth M. Vaughan, Evan Johnson, Aanand D. Naik, Amber B. Amspoker, Ashok Balasubramanyam, Salim S. Virani, Christie M. Ballantyne, Craig A. Johnston, and John P. Foreyt
The impact of the affordable care act on disparities in utilization of cardiovascular preventive services by socioeconomic status, Hannah Verma, Zulqarnain Javed, Jonathan C. Hong, Shiwani Mahajan, Reed Mszar, Gowtham R. Grandhi, Nihar R. Desai, Salim S. Virani, Umair Javed, and Javier Valero-Elizondo
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): A post-hoc analysis of a randomised, double-blind trial, Subodh Verma, Nitish K. Dhingra, Javed Butler, Stefan D. Anker, Joao Pedro Ferreira, Gerasimos Filippatos, James L. Januzzi, Carolyn S P. Lam, Naveed Sattar, and Salim S. Virani
Statins and primary atherosclerotic cardiovascular disease prevention-what we know, where we need to go, and why are we not there already?, Salim S. Virani
The fibrates story - A tepid end to a PROMINENT drug, Salim S. Virani
Guideline-concordant statin therapy use in secondary prevention: Should the medical community wait for divine intervention?, Salim S. Virani, Christie M. Ballantyne, and Laura A. Petersen
Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know, Salim S. Virani, Marlys L. Koschinsky, Lisa Maher, Anurag Mehta, Carl E. Orringer, Raul D. Santos, Michael D. Shapiro, and Joseph J. Saseen
The utility of coronary artery calcium for guiding treatment with preventive pharmacotherapy: Opportunities and nuances, Salim S. Virani and Mahmoud Al Rifai
Lipid-lowering therapy use and intensification among United States veterans following myocardial infarction or coronary revascularization between 2015 and 2019, Alexander R. Zheutlin, Catherine G. Derington, Jennifer S. Herrick, Robert S. Rosenson, Bharat Poudel, Monika M. Safford, Todd M. Brown, Elizabeth A. Jackson, Mark Woodward, and Salim S. Virani
Submissions from 2021
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH), Ali M. Agha, Peter H. Jones, Christie M. Ballantyne, and Salim S. Virani
Transatlantic guidelines on dyslipidemia and cardiovascular risk: Key differences across the pond, Ali M. Agha, Salim S. Virani, and Christie M. Ballantyne
Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease, Tanushree Agrawal, Isaac Acquah, Amit K. Dey, Kerri Glassner, Bincy Abraham, Ron Blankstein, Salim S. Virani, Michael J. Blaha, Javier Valero-Elizondo, and Nehal Mehta
Racial and geographic disparities in influenza vaccination in the U.S. among individuals with atherosclerotic cardiovascular disease: Renewed importance in the setting of COVID-19, Mahmoud Al Rifai, Umair Khalid, Arunima Misra, Jing Liu, Khurram Nasir, Miguel Cainzos-Achirica, Dhruv Mahtta, Christie M. Ballantyne, Laura A. Petersen, and Salim S. Virani
Cigarette smokers' perceptions of smoking cessation and associated factors in Karachi, Pakistan, Rubina Barolia, Sajid Iqbal, Salim S. Virani, Faris Khan, and Pammla Petrucka
Ten things to know about ten cardiovascular disease risk factors, Harold E. Bays, Pam R. Taub, Elizabeth Epstein, Erin D. Michos, Richard A. Ferraro, Alison Bailey, Heval M. Kelli, Keith C. Ferdinand, Melvin R. Echols, and Salim S. Virani
Determinants of influenza vaccine uptake in patients with cardiovascular disease and strategies for improvement, Priyanka Bhugra, Gowtham R. Grandhi, Reed Mszar, Priyanka Satish, Rahul Singh, Michael Blaha, Ron Blankstein, Salim S. Virani, Miguel Cainzos-Achirica, and Khurram Nasir
Predictors of PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor prescriptions for secondary prevention of clinical atherosclerotic cardiovascular disease, Daniel M. Blumenthal, Thomas M. Maddox, Krishna Aragam, Chana A. Sacks, Salim S. Virani, and Jason H. Wasfy
Gender disparities in difficulty accessing healthcare and cost-related medication non-adherence: The CDC behavioral risk factor surveillance system (BRFSS) survey, Marilyne Daher, Mahmoud Al Rifai, Riyad Y. Kherallah, Fatima Rodriguez, Dhruv Mahtta, Erin D. Michos, Safi U. Khan, Laura A. Petersen, and Salim S. Virani
Substance use and premature atherosclerotic cardiovascular disease (from the CDC behavioral risk factor surveillance system [BRFSS] survey), Marilyne Daher, Mahmoud Al Rifai, Dhruv Mahtta, Chayakrit Krittanawong, Jeffrey Berman, Waqas Ullah, Mahboob Alam, and Salim S. Virani
Trends in characteristics and outcomes of hospitalized young patients undergoing coronary artery bypass grafting in the United States, 2004 to 2018, Sourbha S. Dani, Abdul Mannan Khan Minhas, Adeel Arshad, Troy Krupica, Sachin S. Goel, Salim S. Virani, Garima Sharma, Ron Blankstein, Michael J. Blaha, and Sadeer G. Al‐Kindi
Lipid monitoring after initiation of lipid-lowering therapies: Return of performance measures?, Matthew R. Deshotels, Salim S. Virani, and Christie M. Ballantyne
Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendations, David I. Feldman, Erin D. Michos, Neil J. Stone, Ty J. Gluckman, Miguel Cainzos-Achirica, Salim S. Virani, and Roger S. Blumenthal
Association of reproductive factors with dementia: A systematic review and dose-response meta-analyses of observational studies, Chunying Fu, Wenting Hao, Nipun Shrestha, Salim S. Virani, Shiva Raj Mishra, and Dongshan Zhu
Association of blood pressure variability and diuretics with cardiovascular events in patients with chronic kidney disease stages 1-5, L Parker Gregg, S Susan Hedayati, Hui Yang, Peter N Van Buren, Subhash Banerjee, Sankar D. Navaneethan, Salim S. Virani, Wolfgang C. Winkelmayer, and Carlos A. Alvarez
High-intensity statins benefit high-risk patients: Why and how to do better, Scott M. Grundy, Neil J. Stone, Roger S. Blumenthal, Lynne T. Braun, Paul A. Heidenreich, Donald Lloyd-Jones, Carl E. Orringer, Joseph J. Saseen, Sidney C. Smith, and Salim S. Virani
Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR® PINNACLE registry, Kevin Gu, Dhruv Mahtta, Amar Kaneria, Parija Sharedalal, Brittany Dennis, Yang Song, Xin Wei, Umair Khalid, Paul Hess, and Salim S. Virani
The risk and severity of stroke in patients with atrial fibrillation and gout: A national representative database study, Faris Haddadin, Ana B. Arevalo, Ahmad Jabri, Hassan Beydoun, Farah Fram, Alba Munoz Estrella, Saima Karim, Salim S. Virani, and Yousaf Ali
Use of oral anticoagulants in patients with valvular atrial fibrillation: Findings from the NCDR PINNACLE Registry, Paul L. Hess, Kensey L. Gosch, Sandeep M. Jani, Paul D. Varosy, Steven M. Bradley, Thomas M. Maddox, P Michael Ho, and Salim S. Virani
Epidemiology and risk factors for stroke in young individuals: Implications for prevention, Aliza Hussain, Michelle Lee, Jamal Rana, and Salim S. Virani
Highlights from studies presented at the American Heart Association scientific session 2020: Navigating new roads in prevention, Aliza Hussain, Mahmoud Al Rifai, Dhruv Mahtta, Jing Liu, Vardhmaan Jain, and Salim S. Virani
Association of NT-ProBNP, blood pressure, and cardiovascular events: The ARIC study, Aliza Hussain, Wensheng Sun, Anita Deswal, James A de Lemos, John W. McEvoy, Ron C. Hoogeveen, Kunihiro Matsushita, David Aguilar, Biykem Bozkurt, and Salim S. Virani
Soluble angiotensin-converting enzyme 2, cardiac biomarkers, structure, and function, and cardiovascular events (from the atherosclerosis risk in communities study), Aliza Hussain, Olive Tang, Caroline Sun, Xiaoming Jia, Elizabeth Selvin, Vijay Nambi, Aaron Folsom, Gerardo Heiss, Faiez Zannad, and Salim S. Virani
Racial and geographic disparities in internet use in the U.S. among patients with hypertension or diabetes: Implications for telehealth in the era of COVID-19, Vardhmaan Jain, Mahmoud Al Rifai, Michelle T. Lee, Ankur Kalra, Laura A. Petersen, Elizabeth M. Vaughan, Nathan D. Wong, Christie M. Ballantyne, and Salim S. Virani
Highlights from studies presented at the virtual American College of Cardiology scientific sessions 2021: Staying updated with the latest advancements in prevention, Vardhmaan Jain, Mahmoud Al Rifai, Dhruv Mahtta, Jing Liu, Aliza Hussain, and Salim S. Virani
State-level temporal trends in smokeless tobacco and cigarette use among U.S. adults, Vardhmaan Jain, Mahmoud Al Rifai, Sahar Naderi, Rubina Barolia, Sajid Iqbal, Mehrunnissa Taj, Xiaoming Jia, Anwar T. Merchant, Wilbert S. Aronow, and Salim S. Virani
Association between omega-3 fatty acid treatment and atrial fibrillation in cardiovascular outcome trials: A systematic review and meta-analysis, Xiaoming Jia, Feng Gao, June K. Pickett, Mahmoud Al Rifai, Yochai Birnbaum, Vijay Nambi, Salim S. Virani, and Christie M. Ballantyne
Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system, Xiaoming Jia, Michelle T. Lee, David J. Ramsey, Dhruv Mahtta, Julia M. Akeroyd, Alexander Turchin, Ann Marie Navar, Michael E. Matheny, Glenn Gobbel, and Salim S. Virani
Facility-level variation in reported statin-associated side effects among patients with atherosclerotic cardiovascular disease-perspective from the veterans affair healthcare system, Xiaoming Jia, Michelle T. Lee, David J. Ramsey, Mahmoud Al Rifai, Dhruv Mahtta, Chayakrit Krittanawong, Julia M. Akeroyd, Michael E. Matheny, Glenn Gobbel, and Salim S. Virani
Association between circulating Galectin-3 and arterial stiffness in older adults, Xiaoming Jia, Caroline Sun, Hirofumi Tanaka, Mahmoud Al Rifai, David Aguilar, Chiadi Ndumele, Elizabeth Selvin, Salim S. Virani, Ron C. Hoogeveen, and Gerardo Heiss
Statins in COVID-19 infection: A rehash of old themes or truly a new hope?, Xiaoming Jia and Salim S. Virani
Social determinants of health and cardiovascular disease: Current state and future directions towards healthcare equity, Mohammad Hashim Jilani, Zulqarnain Javed, Tamer Yahya, Javier Valero-Elizondo, Safi U. Khan, Bita Kash, Ron Blankstein, Salim S. Virani, Michael J. Blaha, and Prachi Dubey
Oral antiplatelet therapy after acute coronary syndrome: A review, Hassan Kamran, Hani Jneid, Waleed T. Kayani, Salim S. Virani, Glenn N. Levine, Vijay Nambi, and Umair Khalid
How low is safe? The frontier of very low ( <30 mg>/dL) LDL cholesterol, Angelos D. Karagiannis, Anurag Mehta, Devinder S. Dhindsa, Salim S. Virani, Carl E. Orringer, Roger S. Blumenthal, Neil J. Stone, and Laurence S. Sperling
Eligibility for low-dose rivaroxaban based on the COMPASS trial: Insights from the veterans affairs healthcare system, Akash Kataruka, Dhruv Mahtta, Julia M. Akeroyd, Ravi S. Hira, Dhruv S. Kazi, John A. Spertus, Deepak L. Bhatt, Laura A. Petersen, Christie M. Ballantyne, and Salim S. Virani
The COVID-19 pandemic: A catalyst for creativity and collaboration for online learning and work-based higher education systems and processes, Tashmin Khamis, Azra Naseem, Anil Khamis, and Pammla Petrucka
Social vulnerability and premature cardiovascular mortality among US counties, 2014 to 2018, Safi U. Khan, Zulqarnain Javed, Ahmad N. Lone, Sourbha S. Dani, Zahir Amin, Sadeer G. Al-Kindi, Salim S. Virani, Garima Sharma, Ron Blankstein, and Michael J. Blaha
Stroke-related mortality in the United States-Mexico border area of the United States, 1999 to 2018, Safi U. Khan, Ankur Kalra, Siva H. Yedlapati, Sourbha S. Dani, Michael D. Shapiro, Khurram Nasir, Salim S. Virani, Erin D. Michos, and Mohamad Alkhouli
Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis, Safi U. Khan, Ahmad N. Lone, Muhammad Shahzeb Khan, Salim S. Virani, Roger S. Blumenthal, Khurram Nasir, Michael Miller, Erin D. Michos, Christie M. Ballantyne, and William E. Boden
Prevalence and predictors of cost-related medication nonadherence in individuals with cardiovascular disease: Results from the Behavioral Risk Factor Surveillance System (BRFSS) survey, Riyad Kherallah, Mahmoud Al Rifai, Ishan Kamat, Chayakrit Krittanawong, Dhruv Mahtta, Michelle T. Lee, Jing Liu, Khurram Nasir, Javier Valero-Elizondo, and Salim S. Virani
Gender differences in premature coronary artery disease (from the national data from the NHANES database), Chayakrit Krittanawong, Marilyne Daher, Joshua Hahn, Bharat Narasimhan, Zhen Wang, Mahboob Alam, Hani Jneid, and Salim S. Virani
A comparison of cardiovascular risk factors between Asian-Americans and non-Asian Americans: An analysis from the NHANES database, Chayakrit Krittanawong, Joshua Hahn, Marilyne Daher, Dhruv Mahtta, Bharat Narasimhan, Zhen Wang, Dhrubajyoti Bandyopadhyay, Samin K. Sharma, Mahboob Alam, and Salim S. Virani
Mushroom consumption and cardiovascular health: A systematic review, Chayakrit Krittanawong, Ameesh Isath, Joshua Hahn, Zhen Wang, Sonya E. Fogg, Dhrubajyoti Bandyopadhyay, Hani Jneid, Salim S. Virani, and W H Wilson Tang
Fish consumption and cardiovascular health: A systematic review, Chayakrit Krittanawong, Ameesh Isath, Joshua Hahn, Zhen Wang, Bharat Narasimhan, Scott L. Kaplin, Hani Jneid, Salim S. Virani, and W.H. Wilson Tang
Social media and predictive analysis regarding dietary approaches to stop hypertension, Chayakrit Krittanawong, Scott Kaplin, W H Wilson Tang, Hani Jneid, Salim S. Virani, and Franz H. Messerli
Clinical characteristics and mortality after acute myocardial infarction-related hospitalization among Asians from a national population-based cohort study, Chayakrit Krittanawong, Dhruv Mahtta, Bharat Narasimhan, Zhen Wang, Dhrubajyoti Bandyopadhyay, Bashir Hanif, Zainab Samad, Takeshi Kitai, Mahboob Alam, Samin K. Sharma, Hani Jneid, and Salim S. Virani
Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease, Michelle T. Lee, Dhruv Mahtta, Mahboob Alam, Waqas Ullah, Khurram Nasir, Bashir Hanif, and Salim S. Virani
Premature atherosclerotic cardiovascular disease risk among patients with inflammatory bowel disease, Michelle T. Lee, Dhruv Mahtta, Liang Chen, Aliza Hussain, Mahmoud Al Rifai, Preetika Sinh, Umair Khalid, Khurram Nasir, Christie M. Ballantyne, and Salim S. Virani
Highlights of cardiovascular disease studies presented at the 2021 European Society of Cardiology Congress, Michelle T. Lee, Dhruv Mahtta, Louis Dlouhy, Hunaina Shahab, Mahmoud Al Rifai, and Salim S. Virani
Sex-related disparities in cardiovascular health care among patients with premature atherosclerotic cardiovascular disease, Michelle T. Lee, Dhruv Mahtta, David J. Ramsey, Jing Liu, Arunima Misra, Khurram Nasir, Zainab Samad, Dipti Itchhaporia, Safi U. Khan, Richard S. Schofield, Christie M. Ballantyne, Laura A. Petersen, and Salim S. Virani
Patient perceptions and use of non-statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry, Angela Lowenstern, Shuang Li, Ann Marie Navar, Salim S. Virani, Veronique L. Roger, Jennifer G. Robinson, Anne C. Goldberg, Wendy Kampman, Eric D. Peterson, and Tracy Y. Wang
Scope and social determinants of food insecurity among adults with atherosclerotic cardiovascular disease in the United States, Shiwani Mahajan, Gowtham R. Grandhi, Javier Valero-Elizondo, Reed Mszar, Rohan Khera, Isaac Acquah, Tamer Yahya, Salim S. Virani, Ron Blankstein, and Michael J. Blaha
Methodological rigor and temporal trends of cardiovascular medicine meta-analyses in highest-impact journals, Dhruv Mahtta, Ahmed Altibi, Mohamed M. Gad, Amjad Samara, Amr F. Barakat, Rodrigo Bagur, Hend Mansoor, Hani Jneid, Salim S. Virani, and Mamas A. Mamas
Promise and perils of telehealth in the current era, Dhruv Mahtta, Marilyne Daher, Michelle T. Lee, Saleem Sayani, Mehdi Shishehbor, and Salim S. Virani
Significant facility-level variation in utilization of and adherence with secondary prevention therapies among patients with premature atherosclerotic cardiovascular disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) registry7, Dhruv Mahtta, Michelle T. Lee, David J. Ramsey, Julia M. Akeroyd, Chayakrit Krittanawong, Safi U. Khan, Preetika Sinh, Mahboob Alam, Kirk N. Garratt, and Salim S. Virani
Recreational substance use among patients with premature atherosclerotic cardiovascular disease, Dhruv Mahtta, David Ramsey, Chayakrit Krittanawong, Mahmoud Al Rifai, Nasir Khurram, Zainab Samad, Hani Jneid, Christie Ballantyne, Laura A. Petersen, and Salim S. Virani
Trends in pneumococcal vaccination in patients presenting with acute coronary syndrome in the United States, Bharat Narasimhan, Scott L. Kaplin, Harish Narasimhan, Zhen Wang, Dhrubajyoti Bandyopadhyay, Hani Jneid, Salim S. Virani, and Chayakrit Krittanawong
Patient-perceived versus actual risk of cardiovascular disease and associated willingness to consider and use prevention therapy, Ann Marie Navar, Tracy Y. Wang, Shuang Li, Xiaojuan Mi, Zhuokai Li, Jennifer G. Robinson, Salim S. Virani, and Eric D. Peterson
Shared decision making and patient reported outcomes among adults with atherosclerotic cardiovascular disease, medical expenditure panel survey 2006-2015, Victor Okunrintemi, Javier Valero-Elizondo, Neil J. Stone, Ron Blankstein, Michael J. Blaha, Martha Gulati, Salim S. Virani, William A. Zoghbi, Erin D. Michos, and Khurram Nasir
Hypertension guidelines and coronary artery calcification among South Asians: Results from MASALA and MESA, Jaideep Patel, Anurag Mehta, Mahmoud Al Rifai, Michael J. Blaha, Khurram Nasir, John W. McEvoy, Ambarish Pandey, Alka M. Kanaya, Namratha R. Kandula, and Salim S. Virani
Assessment of coronary artery calcium scoring to guide statin therapy allocation according to risk-enhancing factors: The multi-ethnic study of atherosclerosis, Jaideep Patel, Vincent A. Pallazola, Ramzi Dudum, Philip Greenland, John W. McEvoy, Roger S. Blumenthal, Salim S. Virani, Michael D. Miedema, Steven Shea, and Joseph Yeboah
Health care costs associated with primary care physicians versus nurse practitioners and physician assistants, Suja S. Rajan, Julia M. Akeroyd, Sarah T. Ahmed, David J. Ramsey, Christie M. Ballantyne, Laura A. Petersen, and Salim S. Virani